Bruckner, Tim A.
Parker, Daniel M.
Bartell, Scott M.
Vieira, Veronica M.
Khan, Saahir
Noymer, Andrew
Drum, Emily
Albala, Bruce
Zahn, Matthew
Boden-Albala, Bernadette
Funding for this research was provided by:
Orange County HealthCare Agency
Article History
Received: 27 October 2020
Accepted: 21 January 2021
First Online: 4 February 2021
Competing interests
: Dr. Saahir Khan reports grants from University of California Office of the President and from National Institutes of Health during the conduct of the study. In addition, Dr. Khan has a patent “Devices For Detecting Antibodies To Coronavirus Antigens And Methods for Using Them,” Provisional Patent No. 62/993,610, filed March 23, 2020, licensed to Nanommune Inc. Saahir Khan is a consultant for and owns shares in Nanommune Inc. which is commercializing the technology used in this study. All other Authors (Drs. Bruckner, Parker, Bartell, Vieira, Drum, Noymer, Albala, Boden-Albala, Zahn) declare no potential conflict of interest.